These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


93 related items for PubMed ID: 7127279

  • 1. Schedule optimization of hydroxyurea and 1-beta-D-arabinofuranosylcytosine in sarcoma 180 in vitro.
    Shackney SE, Ford SS, Occhipinti SJ, Ritch PS, Riccardi R, Erickson BW.
    Cancer Res; 1982 Nov; 42(11):4339-47. PubMed ID: 7127279
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cytotoxic and cytokinetic effects of 1-beta-D-arabinofuranosylcytosine, daunorubicin, and 6-thioguanine on HeLa cells in culture.
    Fried J, Perez AG, Doblin JM, Clarkson BD.
    Cancer Res; 1981 Mar; 41(3):1127-32. PubMed ID: 7459856
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Studies on the mechanism of action of 1-beta-D-arabinofuranosylcytosine as an inhibitor of DNA synthesis in human leukemic leukocytes.
    Inagaki A, Nakamura T, Wakisaka G.
    Cancer Res; 1969 Dec; 29(12):2169-76. PubMed ID: 5392487
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and evaluation of anti-tumor activities of N4 fatty acyl amino acid derivatives of 1-beta-arabinofuranosylcytosine.
    Liu B, Cui C, Duan W, Zhao M, Peng S, Wang L, Liu H, Cui G.
    Eur J Med Chem; 2009 Sep; 44(9):3596-600. PubMed ID: 19321234
    [Abstract] [Full Text] [Related]

  • 18. Biochemical effects of 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil and 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mouse leukemic cells sensitive and resistant to 1-beta-D-arabinofuranosylcytosine.
    Chou TC, Burchenal JH, Schmid FA, Braun TJ, Su TL, Watanabe KA, Fox JJ, Philips FS.
    Cancer Res; 1982 Oct; 42(10):3957-63. PubMed ID: 7104996
    [No Abstract] [Full Text] [Related]

  • 19. Mechanism of 1- -D-arabinofuranosylcytosine-induced cell lethality.
    Karon M, Benedict WF, Rucker N.
    Cancer Res; 1972 Dec; 32(12):2612-5. PubMed ID: 4674677
    [No Abstract] [Full Text] [Related]

  • 20. Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-beta-D-arabinofuranosylcytosine.
    Bergerat JP, Drewinko B, Corry P, Barlogie B, Ho DH.
    Cancer Res; 1981 Jan; 41(1):25-30. PubMed ID: 7192598
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.